| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1116.7B | ¥1126.6B | -0.9% |
| Operating Income | ¥103.1B | ¥86.9B | +18.7% |
| Ordinary Income | ¥104.9B | ¥96.0B | +9.3% |
| Net Income | ¥49.8B | ¥69.0B | -27.8% |
| ROE | 5.0% | 7.3% | - |
FY2025 Q3 cumulative results showed revenue of 111.7B yen (YoY -0.9%), operating income of 10.3B yen (+18.7%), ordinary income of 10.5B yen (+9.3%), and net income of 5.0B yen (-27.8%). While the top line remained flat, operating profitability improved significantly through margin expansion and cost control. However, bottom-line profit declined substantially due to special losses of 3.5B yen (including impairment loss of 0.2B yen on polyethylene powder manufacturing equipment at the Chiba plant) and an elevated effective tax rate of 37.1%. The operating margin expanded to 9.2% from 7.7% YoY, reflecting improved gross margin (23.1%) despite revenue stagnation. The divergence between operating income growth and net income decline highlights the impact of non-recurring factors on earnings quality.
Revenue of 111.7B yen decreased 0.9% YoY, indicating flat demand conditions. The Superabsorbent Polymer segment generated 87.4B yen (-0.7% YoY) while the Functional Materials segment recorded 24.0B yen (-1.5% YoY), showing weakness across both core businesses. Despite top-line stagnation, operating income increased 18.7% to 10.3B yen through margin improvement. Gross profit reached 25.8B yen with a gross margin of 23.1%, representing approximately 165 basis points improvement from the prior year's implied margin. Cost of sales decreased more than revenue declined, suggesting better raw material procurement conditions or manufacturing efficiency gains. Selling, general and administrative expenses of 15.5B yen increased in absolute terms but remained controlled relative to revenue. Non-operating income contributed positively, with interest income of 0.3B yen, foreign exchange gains of 0.6B yen, and equity method investment gains, offsetting interest expenses of 0.2B yen. The gap between ordinary income (10.5B yen) and net income (5.0B yen) stems from special losses of 3.5B yen, primarily impairment loss of 0.2B yen on manufacturing equipment in the Functional Materials segment and other extraordinary items. The effective tax rate of 37.1% exceeded the statutory rate, further compressing net income. This represents a "revenue flat / profit mixed" pattern, where operating-level improvements were offset by non-recurring charges and elevated tax burden at the bottom line.
The Superabsorbent Polymer segment generated revenue of 87.4B yen (down 0.7% YoY) and operating income of 8.3B yen (up 28.3% YoY), representing 78.3% of total revenue and 80.1% of total operating profit. This segment serves as the core business with an operating margin of 9.4%, significantly improved from 6.5% in the prior year. The Functional Materials segment recorded revenue of 24.0B yen (down 1.5% YoY) and operating income of 2.0B yen (down 7.4% YoY), accounting for 21.5% of revenue and 19.8% of operating profit. The operating margin of 8.5% declined from 9.0% YoY, impacted by the impairment loss of 0.2B yen on polyethylene powder manufacturing equipment at the Chiba plant. The margin differential of 0.9 percentage points favors the Superabsorbent Polymer segment, which demonstrated stronger profitability recovery despite similar revenue trends. The Other segment contributed marginally with 0.2B yen in revenue and minimal operating profit. The divergent profit trends between segments indicate that Superabsorbent Polymer operations drove the consolidated operating income improvement while Functional Materials faced operational challenges requiring asset write-downs.
[Profitability] ROE of 5.0% declined from 7.3% YoY, driven by net income contraction despite equity base expansion. Operating margin improved to 9.2% from 7.7% YoY (+150 basis points), indicating enhanced operating leverage. Net profit margin of 4.5% declined from 6.1% YoY due to special losses and tax burden. [Cash Quality] Cash and deposits of 19.6B yen provide coverage of 2.73 times short-term debt (7.2B yen), indicating robust liquidity. [Investment Efficiency] Total asset turnover of 0.742 remained stable. Construction in progress of 23.7B yen represents 42.5% of property, plant and equipment (55.7B yen), signaling significant ongoing capital deployment with delayed completion. Accounts receivable of 36.3B yen and inventory of 20.2B yen combine for working capital of 47.7B yen, with days sales outstanding of 119 days and days inventory outstanding of 86 days reflecting slower cash conversion. [Financial Health] Equity ratio of 66.4% compared to 66.6% in the prior year demonstrates maintained financial stability. Current ratio of 225.5% and quick ratio of 172.4% provide comfortable short-term solvency cushions. Debt-to-equity ratio of 0.51 remains conservative. Long-term borrowings increased sharply to 10.9B yen from 5.0B yen YoY (+118.0%), while short-term borrowings decreased to 7.2B yen from 13.3B yen (-46.2%), indicating debt maturity restructuring toward longer tenors.
Cash and deposits increased 13.7B yen YoY to 19.6B yen, reflecting accumulated operating profit contributions and borrowing activities. The sharp increase in long-term borrowings by 5.9B yen coupled with a reduction in short-term borrowings by 6.2B yen indicates refinancing toward longer-term debt structures, likely to fund the substantial construction in progress balance of 23.7B yen. Working capital efficiency showed signs of deterioration with accounts receivable rising 2.3B yen YoY and inventory increasing 1.9B yen, absorbing operating cash generation. Trade payables increased 1.3B yen, providing partial offset through extended supplier credit. The working capital cycle of 142 days (119 days DSO + 86 days DIO - 63 days DPO) lengthened from prior periods, indicating slower conversion of sales into cash. Total assets expanded 90.3B yen to 150.6B yen, driven primarily by the 18.9B yen increase in construction in progress, suggesting active capital investment that has not yet transitioned to productive assets. Cash coverage of short-term liabilities at 2.73 times and the current ratio of 225.5% affirm adequate near-term liquidity despite working capital absorption pressures.
Ordinary income of 10.5B yen versus operating income of 10.3B yen reflects a modest net non-operating contribution of 0.2B yen. Non-operating income of 1.8B yen comprised primarily interest income of 0.3B yen, foreign exchange gains of 0.6B yen, and equity method investment income. Non-operating expenses of 1.6B yen included interest expense of 0.2B yen and foreign exchange losses of 0.03B yen. Non-operating income represents 1.6% of revenue, consisting mainly of financial and operational items rather than extraordinary gains. The gap between ordinary income (10.5B yen) and income before tax (7.9B yen) of 2.6B yen stems from special losses totaling 3.5B yen, partially offset by special gains of 0.9B yen. Special losses included impairment loss of 0.2B yen on manufacturing equipment in the Functional Materials segment, indicating asset valuation adjustments that are non-recurring in nature but reflect underlying operational challenges. The effective tax rate of 37.1% exceeded standard rates, potentially due to discrete items or non-deductible expenses. With quarterly cash flow statement data unavailable, operating cash flow relative to net income cannot be directly assessed, but the working capital buildup (longer DSO and DIO) suggests cash earnings lag accounting income. The combination of non-recurring impairment charges, elevated tax burden, and working capital absorption constrains overall earnings quality despite operating margin improvement.
Full-year guidance targets revenue of 148.0B yen, operating income of 15.0B yen, ordinary income of 15.0B yen, and net income of 7.0B yen. Q3 cumulative progress rates are revenue 75.5%, operating income 68.7%, ordinary income 70.0%, and net income 71.1%. Revenue progress tracks 0.5 percentage points ahead of the standard 75% benchmark for Q3, indicating slight outperformance. Operating income progress of 68.7% lags the standard by 6.3 percentage points, suggesting backend weighting is required to achieve the full-year target. This implies Q4 operating income must reach 4.7B yen, 14.3% below the Q3 quarterly run rate of 5.5B yen (assuming Q1-Q3 average). Net income progress of 71.1% is 3.9 percentage points below standard but aligns reasonably given the special loss impact in Q3. To achieve full-year net income of 7.0B yen, Q4 requires 2.0B yen, implying a normalized quarter without significant special losses. The company has not revised guidance, indicating management confidence that Q4 operations will deliver required performance despite Q3 operating income undershoot. Implied full-year growth rates are revenue +0.3% YoY, operating income +40.0% YoY, and ordinary income +35.1% YoY, reflecting profit recovery trajectory offsetting flat revenue environment.
The company plans an interim dividend of 100 yen per share and a year-end dividend of 100 yen per share, totaling 200 yen annually. Compared to full-year guidance dividend of 120 yen per share, clarification is needed on the discrepancy. Based on the 200 yen total annual dividend assumption and shares outstanding of 13.99 million, total dividends would be 2.8B yen. Against net income of 5.0B yen for the nine-month period, the implied payout ratio is 56.1%. Against full-year net income guidance of 7.0B yen, the payout ratio would be 39.9%. The dividend level represents a stable policy approach despite earnings volatility, supported by strong cash position of 19.6B yen. No share buyback activities were disclosed for the period. The total shareholder return ratio (dividends plus buybacks divided by net income) equals the payout ratio of 39.9% to 56.1% depending on which earnings base is used, indicating moderate capital return relative to retained earnings for investment purposes.
Revenue stagnation and demand visibility risk: Revenue declined 0.9% YoY with both Superabsorbent Polymer (down 0.7%) and Functional Materials (down 1.5%) segments showing weakness, indicating limited near-term growth catalysts and potential demand softness in key end markets. Sustained flat or declining top-line performance constrains operating leverage and limits absolute profit growth potential. Working capital management deterioration risk: Days sales outstanding increased to 119 days and days inventory outstanding to 86 days, resulting in a cash conversion cycle of 142 days, signaling slower receivables collection and inventory turnover. Prolonged working capital absorption reduces free cash flow generation and could pressure liquidity if operational cash generation weakens further. Construction in progress execution and impairment risk: Construction in progress balance of 23.7B yen represents 42.5% of total property, plant and equipment, indicating substantial capital tied up in incomplete projects. The impairment loss of 0.2B yen recorded on Chiba plant equipment in Q3 raises concerns about project completion delays, cost overruns, or demand shortfalls that could lead to additional write-downs if invested capital fails to generate anticipated returns.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of 5.0% is in line with the manufacturing industry median of 5.2% (IQR: 3.0%-8.3%, n=100), placing the company at the median level among peers. Operating margin of 9.2% exceeds the industry median of 8.7% (IQR: 5.1%-12.6%, n=100), indicating above-median operational efficiency. Net profit margin of 4.5% falls below the industry median of 6.4% (IQR: 3.3%-9.3%, n=100), reflecting the impact of special losses and elevated tax burden that compressed bottom-line profitability despite operating strength.
Financial Health: Equity ratio of 66.4% is positioned above the industry median of 63.8% (IQR: 49.4%-74.5%, n=100), confirming a conservative capital structure with above-average financial stability. Current ratio of 225.5% falls below the industry median of 283% (IQR: 211%-380%, n=82), though remaining in a comfortable range for short-term liquidity.
Efficiency: Asset turnover of 0.742 exceeds the industry median of 0.58 (IQR: 0.41-0.66, n=100), indicating superior asset utilization relative to peers. Receivables turnover of 119 days is materially worse than the industry median of 83 days (IQR: 68-114 days, n=99), signaling collection efficiency below industry norms. Inventory turnover of 86 days is better than the industry median of 109 days (IQR: 50-155 days, n=92), reflecting relatively efficient inventory management. Operating working capital cycle of 142 days exceeds the industry median of 108 days (IQR: 71-143 days, n=99), driven primarily by the extended receivables cycle.
Growth: Revenue growth of -0.9% YoY underperforms the industry median growth of +2.8% (IQR: -1.7% to +8.1%, n=100), placing the company in the bottom quartile for top-line expansion.
※ Industry: Manufacturing (N=100 companies), Comparison: FY2025 Q3, Source: Proprietary analysis
Operating profitability recovery with margin expansion: Operating income increased 18.7% YoY while revenue declined 0.9%, resulting in operating margin improvement to 9.2% from 7.7% and exceeding the manufacturing industry median of 8.7%. The Superabsorbent Polymer segment achieved particularly strong margin expansion to 9.4% from 6.5%, demonstrating pricing power or cost efficiency gains that warrant continued monitoring to assess sustainability. However, the flat revenue environment limits absolute profit growth potential and suggests reliance on margin management rather than volume-driven expansion. Working capital efficiency deterioration pressuring cash conversion: Days sales outstanding of 119 days and days inventory outstanding of 86 days combine for a cash conversion cycle of 142 days, substantially exceeding the industry median of 108 days and indicating below-peer working capital management. The receivables position of 119 days is 36 days longer than the industry median of 83 days, pointing to collection challenges or extended customer payment terms. This working capital buildup absorbs cash generation and represents a key operational focus area for liquidity preservation and free cash flow improvement. Capital deployment concentration with elevated construction in progress: Construction in progress of 23.7B yen represents 42.5% of property, plant and equipment, financed partially by long-term borrowings that increased 5.9B yen YoY to 10.9B yen. The impairment charge of 0.2B yen on Chiba plant equipment signals execution risk on capital projects. The substantial capital tied up in incomplete projects represents concentrated investment exposure, requiring monitoring of project completion timelines, cost discipline, and demand validation to ensure adequate returns and avoid further write-downs.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.